{"id":16850,"date":"2026-07-24T12:17:11","date_gmt":"2026-07-24T10:17:11","guid":{"rendered":"https:\/\/q-finity.de\/eu-gmp-annex-22\/"},"modified":"2026-08-12T14:01:44","modified_gmt":"2026-08-12T12:01:44","slug":"eu-gmp-annex-22","status":"publish","type":"page","link":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","title":{"rendered":"EU GMP Annex 22"},"content":{"rendered":"\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":16851,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-16850","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EU GMP Annex 22: The Draft AI Annex | QFINITY<\/title>\n<meta name=\"description\" content=\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU GMP Annex 22: The Draft AI Annex | QFINITY\" \/>\n<meta property=\"og:description\" content=\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:site_name\" content=\"QFINITY\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T12:01:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"EU GMP Annex 22\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"name\":\"EU GMP Annex 22: The Draft AI Annex | QFINITY\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e.png\",\"datePublished\":\"2026-07-24T10:17:11+00:00\",\"dateModified\":\"2026-08-12T12:01:44+00:00\",\"description\":\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\",\"url\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e.png\",\"contentUrl\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e.png\",\"width\":1920,\"height\":1071,\"caption\":\"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/q-finity.de\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU GMP Annex 22\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"name\":\"QFINITY\",\"description\":\"Qualit\u00e4tsmanagement &amp; - sicherung\",\"publisher\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/q-finity.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\",\"name\":\"QFINITY\u221e\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\/\\/mlsqau6zetur.i.optimole.com\\/cb:frAi.c2d9\\/w:512\\/h:512\\/q:mauto\\/f:best\\/https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2021\\/03\\/cropped-cropped-signet_PAN_orange.png\",\"contentUrl\":\"https:\\/\\/mlsqau6zetur.i.optimole.com\\/cb:frAi.c2d9\\/w:512\\/h:512\\/q:mauto\\/f:best\\/https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2021\\/03\\/cropped-cropped-signet_PAN_orange.png\",\"width\":512,\"height\":512,\"caption\":\"QFINITY\u221e\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/q-finity-quality-management\\\/\",\"https:\\\/\\\/www.instagram.com\\\/qfinity_official\\\/\"],\"founder\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\"}},{\"@type\":\"FAQPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#faq\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When does Annex 22 take effect?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No date is set. The consultation closed in October 2025 and the EMA's two-day expert workshop took place on 30 June and 1 July 2026; a workshop report has been announced, with a revised draft expected next, followed by finalization and transition periods. Until then, the computerized system is validated under Annex 11 - with quality risk management per ICH Q9(R1) guiding the depth of evidence.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 apply to LLMs and generative AI?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Formally they fall outside its scope - yet it is precisely about them that the draft makes its clearest statement: they should not be used in critical GMP applications, and the evidence sections apply only to static models with deterministic output. Outside critical applications their use remains possible - always with human review of the outputs, and responsibility stays with the regulated company. This very boundary is the central point of contention in the consultation, and the final text may well read differently here.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 replace Annex 11?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Annex 22 is designed as supplementary guidance to Annex 11: the computerized system remains validated under Annex 11; Annex 22 additionally governs the evidence for the embedded model - from intended use to operation.\"}},{\"@type\":\"Question\",\"name\":\"How do the model, the AI system and the AI subsystem relate?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Annex 22 focuses on the model - training, testing and the evidence of its fitness for purpose. We take a wider view: an AI system or AI subsystem brings together one or more models and additional functions, such as controls (often called \\\"guardrails\\\"), into a single system component. Performance can then be measured at several levels, which means verifying the fitness for purpose of every subcomponent and of the way they work together.\"}},{\"@type\":\"Question\",\"name\":\"What can operating companies do today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Everything that matters: inventory the AI applications, document intended use and criticality, define test metrics, secure independent test data, establish monitoring and human oversight. Every one of these building blocks can be put in place today under the current Annex 11, with ICH Q9(R1) guiding the depth of evidence - the draft merely makes them explicit for AI models.\"}}],\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\",\"name\":\"Oliver Herrmann\",\"jobTitle\":\"Founder & CEO\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"worksFor\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/olherrmann\\\/\",\"https:\\\/\\\/virtual.ispe.org\\\/b\\\/sp\\\/oliver-herrmann-4399\"],\"knowsAbout\":[\"GxP-Compliance\",\"Computer System Validation\",\"Computer Software Assurance\",\"Data Integrity\",\"ALCOA++\",\"AI Governance\",\"GAMP 5\"],\"image\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/06\\/oliver-herrmann-qfinity-ceo-scaled.jpg\",\"description\":\"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).\",\"memberOf\":{\"@type\":\"Organization\",\"name\":\"International Society for Pharmaceutical Engineering (ISPE)\",\"url\":\"https:\\\/\\\/ispe.org\"},\"hasCredential\":[{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"degree\",\"name\":\"Graduate Computer Scientist (Dipl.-Inf.)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"Microsoft Certified Systems Engineer (MCSE)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"SAFe (Scaled Agile Framework)\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EU GMP Annex 22: The Draft AI Annex | QFINITY","description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_locale":"en_US","og_type":"article","og_title":"EU GMP Annex 22: The Draft AI Annex | QFINITY","og_description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","og_url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_site_name":"QFINITY","article_modified_time":"2026-08-12T12:01:44+00:00","og_image":[{"url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"EU GMP Annex 22","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","name":"EU GMP Annex 22: The Draft AI Annex | QFINITY","isPartOf":{"@id":"https:\/\/q-finity.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"image":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"thumbnailUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e.png","datePublished":"2026-07-24T10:17:11+00:00","dateModified":"2026-08-12T12:01:44+00:00","description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","breadcrumb":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e.png","width":1920,"height":1071,"caption":"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation"},{"@type":"BreadcrumbList","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/q-finity.de\/en\/home\/"},{"@type":"ListItem","position":2,"name":"EU GMP Annex 22"}]},{"@type":"WebSite","@id":"https:\/\/q-finity.de\/en\/#website","url":"https:\/\/q-finity.de\/en\/","name":"QFINITY","description":"Qualit\u00e4tsmanagement &amp; - sicherung","publisher":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/q-finity.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/q-finity.de\/en\/#organization","name":"QFINITY\u221e","url":"https:\/\/q-finity.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","width":512,"height":512,"caption":"QFINITY\u221e"},"image":{"@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/q-finity-quality-management\/","https:\/\/www.instagram.com\/qfinity_official\/"],"founder":{"@id":"https:\/\/q-finity.de\/en\/#founder"}},{"@type":"FAQPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#faq","mainEntity":[{"@type":"Question","name":"When does Annex 22 take effect?","acceptedAnswer":{"@type":"Answer","text":"No date is set. The consultation closed in October 2025 and the EMA's two-day expert workshop took place on 30 June and 1 July 2026; a workshop report has been announced, with a revised draft expected next, followed by finalization and transition periods. Until then, the computerized system is validated under Annex 11 - with quality risk management per ICH Q9(R1) guiding the depth of evidence."}},{"@type":"Question","name":"Does Annex 22 apply to LLMs and generative AI?","acceptedAnswer":{"@type":"Answer","text":"Formally they fall outside its scope - yet it is precisely about them that the draft makes its clearest statement: they should not be used in critical GMP applications, and the evidence sections apply only to static models with deterministic output. Outside critical applications their use remains possible - always with human review of the outputs, and responsibility stays with the regulated company. This very boundary is the central point of contention in the consultation, and the final text may well read differently here."}},{"@type":"Question","name":"Does Annex 22 replace Annex 11?","acceptedAnswer":{"@type":"Answer","text":"No. Annex 22 is designed as supplementary guidance to Annex 11: the computerized system remains validated under Annex 11; Annex 22 additionally governs the evidence for the embedded model - from intended use to operation."}},{"@type":"Question","name":"How do the model, the AI system and the AI subsystem relate?","acceptedAnswer":{"@type":"Answer","text":"Annex 22 focuses on the model - training, testing and the evidence of its fitness for purpose. We take a wider view: an AI system or AI subsystem brings together one or more models and additional functions, such as controls (often called \"guardrails\"), into a single system component. Performance can then be measured at several levels, which means verifying the fitness for purpose of every subcomponent and of the way they work together."}},{"@type":"Question","name":"What can operating companies do today?","acceptedAnswer":{"@type":"Answer","text":"Everything that matters: inventory the AI applications, document intended use and criticality, define test metrics, secure independent test data, establish monitoring and human oversight. Every one of these building blocks can be put in place today under the current Annex 11, with ICH Q9(R1) guiding the depth of evidence - the draft merely makes them explicit for AI models."}}],"isPartOf":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"}},{"@type":"Person","@id":"https:\/\/q-finity.de\/en\/#founder","name":"Oliver Herrmann","jobTitle":"Founder & CEO","url":"https:\/\/q-finity.de\/en\/","worksFor":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"sameAs":["https:\/\/www.linkedin.com\/in\/olherrmann\/","https:\/\/virtual.ispe.org\/b\/sp\/oliver-herrmann-4399"],"knowsAbout":["GxP-Compliance","Computer System Validation","Computer Software Assurance","Data Integrity","ALCOA++","AI Governance","GAMP 5"],"image":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/06\/oliver-herrmann-qfinity-ceo-scaled.jpg","description":"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).","memberOf":{"@type":"Organization","name":"International Society for Pharmaceutical Engineering (ISPE)","url":"https:\/\/ispe.org"},"hasCredential":[{"@type":"EducationalOccupationalCredential","credentialCategory":"degree","name":"Graduate Computer Scientist (Dipl.-Inf.)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"Microsoft Certified Systems Engineer (MCSE)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"SAFe (Scaled Agile Framework)"}]}]}},"_links":{"self":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/comments?post=16850"}],"version-history":[{"count":4,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions"}],"predecessor-version":[{"id":16870,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions\/16870"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media\/16851"}],"wp:attachment":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media?parent=16850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}